Last10K.com

Parallax Health Sciences, Inc. (PRLX) SEC Filing 8-K Material Event for the period ending Wednesday, May 11, 2022

Parallax Health Sciences, Inc.

HISTORY TOOLS
CIK: 1388410 Ticker: PRLX

View differences made from one to another to evaluate Parallax Health Sciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Parallax Health Sciences, Inc..

Continue

Assess how Parallax Health Sciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Parallax Health Sciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Parallax Health Sciences, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 10: Material Contract
Ticker: PRLX
CIK: 1388410
Form Type: 8-K Corporate News
Accession Number: 0001388410-22-000009
Submitted to the SEC: Wed May 11 2022 7:10:12 PM EST
Accepted by the SEC: Thu May 12 2022
Period: Wednesday, May 11, 2022
Industry: Retail Drug Stores And Proprietary Stores
Events:
  1. Change in Assets
  2. Financial Exhibit
  3. New Agreement

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/prlx/0001388410-22-000009.htm